InvestorsHub Logo

abuhafsa

04/05/18 10:08 AM

#62652 RE: mm2k #62651

It's possible the PSA data is what triggered serious BO discussions and management and board jumped on it.
How else do you explain the total lack of response from IR? There is a complete and total blackout. I sent Noelle another email this morning let's see if she responds. She has always been quick to respond in the past.

ignatiusrielly35

04/05/18 10:10 AM

#62653 RE: mm2k #62651

Someone here gave an example of a biotech that did an offering and announced a buyout one month later. It’s possible that they just need time, and to avoid a “going concern” label.

fbg0316

04/05/18 10:26 AM

#62655 RE: mm2k #62651

Time will tell what is happening. The mosaic theory is the process of gathering seemingly meaningless bits of information in themselves but piecing them together to determine if a larger story is in play. See definition below. So in itself, it may mean nothing that ADXS has had an interim CEO for nine months and doesn't seem in a hurry to find one even though the stock has collapsed 70%. In itself, it may just be pure coincidence that five execs disappeared from the company's wesbite and the company is not responding to inquiries on it (neither confirming or denying the execs left). In itself, it may be coincidence that the only remaining execs were the three that received retention bonuses during as the company put it "time of transition". In itself, it may mean nothing that the CFO recently wrote an article touting how valuable CFOs to companies in the drug development process, an article which doesn't help ADXS but would potentially help her if she were looking for a new job. But put all these pieces together, and maybe, just maybe...

Regarding your point about the recent dilution, it may have simply been done because the deal had not been finalized in full by the time the company's quarterly reporting ended and if the company had less than a year's worth of cash, from a compliance standpoint an audit would disclose the company is a "going concern" and from a governance standpoint a buyer (Amgen say) would have a hard time justifying paying $XX for a company who had recently become a "going concern."

"Under insider trading laws, analysts may not use material non-public information to help select their trades. But traders might be able to piece together non-material non-public information and material public information into a mosaic, which may increase in value when properly compiled and documented."

Simple Steve

04/05/18 10:51 AM

#62666 RE: mm2k #62651

mm2k, to be fair, most buyouts happen without any "one good piece of evidence". A company isn't going to give you much to go on until the announcement. They keep it hush, otherwise they might be accused of violating rules and could be in legal hot water. So investors have to connect the dots and basically go on their hunches or just make an educated guess based on the little info they have. Regarding the recent offering not making sense, hard to know what's in management's mind. Maybe at that time a deal wasn't imminent and they felt they needed more money to keep afloat until end of year. I don't currently own any ADXS but I must say I'm considering buying some because all of this IS unusual. Has anyone been able to contact Noelle today or Lombardi? They're a public company, we should be able to reach them. If we are still unable to today, then something has to be going on.